[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100652555":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":7,"locations":7,"responsibleParty":8,"collaborators":7,"id":12,"slug":13,"hasResults":14,"nctId":15,"briefTitle":16,"officialTitle":16,"acronym":17,"eligibilityCriteria":18,"healthyVolunteers":14,"sex":19,"minAge":20,"maxAge":21,"enrollmentInfo":22,"targetDuration":7,"studyType":25,"phases":7,"briefSummary":26,"conditions":27,"keywords":30,"overallStatus":34,"whyStopped":7,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":7},{"fullName":5,"class":6},"Assiut University","OTHER",null,{"type":9,"investigatorFullName":10,"investigatorTitle":11,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Noha Ahmed Mohamed Refaat Askalany","Assistant lecturer","100652555","application-of-different-scores-in-predicting-outcomes-of-cirrhotic-patients-awaiting-liver-transplantation-100652555",false,"NCT07777705","Application of Different Scores in Predicting Outcomes of Cirrhotic Patients Awaiting Liver Transplantation","transplant","Inclusion Criteria:\n\n* • All patients with liver cirrhosis (whatever the etiology) eligible for liver transplantation above the age of 18.\n\n  * Written informed consent provided.\n\nExclusion Criteria:\n\n* Old age (above 60 years old)\n* Acute liver cell failure without underlying cirrhosis\n* Absolute contraindications (e.g., uncontrolled sepsis, severe cardiopulmonary dysfunction, active malignancy).\n* Extra-MELD indications (e.g., hepatopulmonary syndrome, refractory ascites, cholestatic pruritus, hepatoblastoma). We restricted our cohort to patients listed for liver transplantation based on MELD-driven indications. This decision was made to reduce heterogeneity and ensure that eligibility determinations were primarily driven by MELD scores, thereby allowing us to isolate the relative contribution of frailty in the context of MELD-based allocation","ALL","18 Years","60 Years",{"count":23,"type":24},153,"ESTIMATED","OBSERVATIONAL","the goal of this observational study is to apply different scores 1. To assess Fatigue, Frailty, Liver Transplant Comorbidity Index and MELD 3.0 in patients with liver cirrhosis awaiting liver transplantation.\n\n2\\. To evaluate the predictive accuracy of these Scores for the short-term outcomes (early complications, recurrent hospitalization and 3-month mortality). 3. To determine whether using these Scores in the pre-transplant evaluation improves risk stratification compared to MELD score alone.",[28,29],"Liver Cirrhosis","Liver Transplant",[31,32,33],"cirrhosis and transplantation","Liver cirrhosis","Liver transplantation","NOT_YET_RECRUITING","2026-08-19",{"date":37,"type":38},"2026-08-20","ACTUAL",{"date":40,"type":24},"2026-09-01",{"date":42,"type":24},"2028-01-01",{"name":5,"class":6}]